Dynamics of Circulatory HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation Using iTACT Assays to Predict Clinical Flares and HBsAg Loss
Alimentary Pharmacology & Therapeutics · 2026-07 · 64 (1) · 89-102
DOI: 10.1111/apt.70658 ↗At a glance
Journal article in Alimentary Pharmacology & Therapeutics, published online on 2026-04-07. Written by Ying-Nan Tsai and 9 co-authors. Institution: Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan. Major MEDLINE topics: Hepatitis B Surface Antigens, Antiviral Agents, Hepatitis B, Chronic, Hepatitis B Core Antigens. Cited 4 times so far (Crossref); 48 references. Funded by: E-Da Hospital, Tomorrow Medical Foundation, Japan Agency for Medical Research and Development.
Abstract (original language)
Background
Circulatory HBsAg and HBcrAg levels may fluctuate after nucleos(t)ide analogue (NA) withdrawal.
Aims
We aimed to characterize their dynamics and evaluate their performance in predicting clinical flares (CF) and HBsAg loss.
Methods
Non‐cirrhotic patients with chronic hepatitis B discontinuing NA according to Asia‐Pacific criteria were enrolled. CF was defined as ALT elevation > 5 times upper limit of normal following viral relapse. Circulatory HBsAg and HBcrAg levels were quantified using iTACT assays at treatment cessation and every 6 months thereafter until retreatment (up to 3 years). Predictive performance was evaluated using time‐dependent models.
Results
Of the 206 patients (median age, 50.0 years; 78.6% male) with a median treatment duration of 37.6 months (47.6% on entecavir), 68 experienced a CF (median follow‐up, 36.1 months) and 30 achieved HBsAg loss (median follow‐up, 70.3 months). Both HBcrAg and HBsAg decreased over time in patients with favourable outcomes (absence of CF or achievement of HBsAg loss). HBcrAg significantly outperformed HBsAg in predicting CF, with higher time‐dependent AUROCs (69.7%–71.3% vs. 57.8%–65.2%). Multivariable analyses confirmed that HBcrAg dynamics predicted CF more accurately (adjusted sub‐distribution hazard ratio [aSHR], 1.71 per log U/mL; 95% CI, 1.48–1.98), whereas HBsAg dynamics were superior in predicting HBsAg loss, with lower levels indicating a higher likelihood of clearance (aSHR, 0.33 per log IU/mL; 95% CI, 0.23–0.47).
Conclusions
HBcrAg dynamics more accurately predict CF, while HBsAg dynamics better predict HBsAg loss after NA cessation, supporting their complementary roles in clinical practice and suggesting distinct biological mechanisms underlying their production.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
- Department of Medical Research, E-Da Hospital, Kaohsiung, Taiwan.
- Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
- Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.
- Department of Epidemiology and Population Health, Stanford University Medical Center, Palo Alto, California, USA.
ORCID profiles: Ying-Nan Tsai, Cheng-Hao Tseng, Mindie H Nguyen, Yasuhito Tanaka, Yao-Chun Hsu
Funding
- E-Da Hospital
- Tomorrow Medical Foundation
- Japan Agency for Medical Research and Development
Cite
APA
Tsai, Y. N., Wu, J. L., Tseng, C. H., Chen, T. H., Chung, Y. C., Nguyen, M. H., Lin, J. T., Nagaoka, K., Tanaka, Y., & Hsu, Y. C. (2026). Dynamics of Circulatory HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation Using iTACT Assays to Predict Clinical Flares and HBsAg Loss. Alimentary Pharmacology & Therapeutics, 64(1), 89-102. https://doi.org/10.1111/apt.70658
Vancouver
Tsai YN, Wu JL, Tseng CH, Chen TH, Chung YC, Nguyen MH, et al. Dynamics of Circulatory HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation Using iTACT Assays to Predict Clinical Flares and HBsAg Loss. Alimentary Pharmacology & Therapeutics. 2026;64(1):89-102. doi:10.1111/apt.70658
BibTeX
@article{Tsai2026,
author = {Tsai, Ying-Nan and Wu, Jia-Ling and Tseng, Cheng-Hao and Chen, Tzu-Haw and Chung, Ying-Chu and Nguyen, Mindie H and Lin, Jaw-Town and Nagaoka, Katsuya and Tanaka, Yasuhito and Hsu, Yao-Chun},
title = {Dynamics of Circulatory HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation Using iTACT Assays to Predict Clinical Flares and HBsAg Loss},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {1},
pages = {89--102},
doi = {10.1111/apt.70658}
}
EUVIMED